BC
BriaCell Therapeutics Corp. (BCT)
TSX
4.82
-0.74 (-13.31%)
Closed
Aug 24, 2026
Day's Range
4.785.55
52 wk Range
3.6820.40
Financial Statements - BCT - BriaCell Therapeutics Corp.
Revenue
0
Net Income
-6.80M▲ 66.5%
EBITDA
-45.61M▼ 80.0%
Free Cash Flow
-33.91M▼ 42.8%
Income Statement
| Period Ending | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -45.97M | -23.27M | -15.28M | -6.97M | -2.76M | -3.57M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 38.77M | 2.07M | -11.68M | -6.76M | -55.62K | 259.37K |
| Pre Tax Income | -6.80M | -20.30M | -26.83M | -13.81M | -2.83M | -3.32M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -6.80M | -20.30M | -26.83M | -13.81M | -2.83M | -3.32M |
| EPS Basic | -43.68 | -1.3 | -1.73 | -0.09 | -5.64 | -8.13 |
| EPS Diluted | -43.68 | -1.3 | -1.73 | -0.09 | -5.64 | -8.13 |
| Basic Shares Outstanding | 151.32K | 11.01M | 10.92M | 3.18M | 503.27K | 408.64K |
| Diluted Shares Outstanding | 151.32K | 11.01M | 10.92M | 3.18M | 503.27K | 408.64K |
| Ebit | -6.80M | -23.27M | -26.83M | -13.73M | -2.81M | -3.30M |
| Ebitda | -45.61M | -25.33M | -15.13M | -6.95M | -2.79M | -3.31M |
| Net Income Continuous Operations | -6.80M | -20.30M | -26.83M | -13.81M | -2.83M | -3.32M |
| Minority Interests | 140.08K | 0 | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
